Neuroendocrine Tumor Research Foundation

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Filter IconFilter

Showing 7 of 7 papers

  • Open Access
  • Research Article

Kinesiophobia and depression in patients with sickle cell disease: A review of gender differences, pathophysiology, and clinical implications.

  • Apr 01, 2026
  • Journal of the National Medical Association
  • Brianna Jones +14
  • Research Article

Coherent OAM generation from discrete chaotic phase surfaces.

  • Mar 16, 2026
  • Scientific reports
  • Netzer Moriya
  • Open Access
  • Research Article

Amx-883, a potent and selective degrader of BRD9 drives differentiation in acute myeloid leukaemia and shows synergistic efficacy in combination with venetoclax In Vivo and prevents the emergence of resistance to venetoclax in vitro.

  • Nov 03, 2025
  • Blood
  • Martin O'rourke +14
  • Open Access
  • Research Article

58MO Advancing salivary gland cancer research: A multidisciplinary approach to addressing the unmet clinical need

  • Mar 01, 2025
  • ESMO Open
  • R Metcalf +18
  • Open Access
  • Research Article

Quantitative analysis of the morphological variation within the tiger beetle Calomera littoralis (Fabricius, 1787) (Coleoptera: Cicindelidae) in Mongolia.

  • Sep 18, 2024
  • Zootaxa
  • John A Shetterly +1
  • Open Access
  • Conference Article

ATIVIDADE LARVICIDA DO COMPLEXO DE INCLUSÃO DO ÓLEO ESSENCIAL DE PSIDIUM CATTLEYANUM S. EM AEDES AEGYPTI L.

  • Jan 01, 2023
  • Luiza Alves Mendes +5
  • Research Article
  • Citations1

Survey of challenges in access to diagnostics and treatment for neuroendocrine tumor patients (SCAN): The diagnostic process of GEP-NETs in Australia, Canada, China, France, Germany, the United Kingdom, and the United States of America.

  • Feb 01, 2022
  • Journal of Clinical Oncology
  • Mark Mcdonnell +13
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.